Up to now, studies of sputum samples from COPD patients have focused on individual levels such as eosinophil counts20, microbiome22, mucin levels23, and metabolomic biomarkers21, and in those, the emphasis was mostly on comparing smokers with nonsmokers. The gene discussed is MUC5AC; the disease is chronic obstructive pulmonary disease.